No Data
Blueprint Medicines(BPMC.US) Officer Sells US$7.71 Million in Common Stock
$Blueprint Medicines(BPMC.US)$ Officer Durso-Bumpus Debra sold 74,034 shares of common stock on Jun 21, 2024 at an average price of $104.19 for a total value of $7.71 million.Source: Announcement What
Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing
Debra Durso-Bumpus, Chief People Officer, on June 21, 2024, sold 74,034 shares in Blueprint Medicines (BPMC) for $7,713,537. Following the Form 4 filing with the SEC, Durso-Bumpus has control over a t
Form 144 | Blueprint Medicines(BPMC.US) Officer Proposes to Sell 9.23 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 21, $Blueprint Medicines(BPMC.US)$ Officer Debra Bumpus intends to sell 87,034 shares of its common stock on Jun 21, with a total market value of approximately $9.23 millio
Investing in Blueprint Medicines (NASDAQ:BPMC) a Year Ago Would Have Delivered You a 78% Gain
The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. To wit, the Blueprint Medicines Corporation (NASDA
Unusual Options Activity: APA, LNG and Others Attract Market Bets, APA V/OI Ratio Reaches 420.0
EST Jun 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Wells Fargo Maintains Blueprint Medicines(BPMC.US) With Buy Rating
Wells Fargo analyst Derek Archila maintains $Blueprint Medicines(BPMC.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 40.2% and a total average return of 5.6% over